Combination Momordica Charantia Extract and Primaquine Againts Plasmodium Falciparum Uncomplicated and Plasmodium Vivax Uncomplicated Treatment in Manokwari, West Papua

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 11, 2019

Primary Completion Date

April 16, 2019

Study Completion Date

April 16, 2019

Conditions
Malaria,FalciparumMalaria, VivaxMalariaInfectionsUncomplicated MalariaUncomplicated Plasmodium Falciparum
Interventions
DRUG

Dihydroartemisinin

dihidroartemisinin dose of 2-4 mg/Kg Body weight taken for 3 days

DRUG

Piperaquine

piperaquine at a dose of 16-32 mg/Kg body weight taken for 3 days

DRUG

Primaquine

Primaquine dose 0.25 mg/kg body weight given to uncomplicated Plasmodium falciparum patients on the first day only

OTHER

Momordica Charantia Extract

Momordica charantia extract capsules at a dose of 325 mg were given to patients for 3 days

Trial Locations (1)

Unknown

Manokwari Regional General Hospital, Manokwari

All Listed Sponsors
collaborator

Dr Cipto Mangunkusumo General Hospital

OTHER

collaborator

PT Natura Nuswantara Nirmala

UNKNOWN

lead

Syamsudin Abdillah,Ph.D, Pharm D

OTHER

NCT06036030 - Combination Momordica Charantia Extract and Primaquine Againts Plasmodium Falciparum Uncomplicated and Plasmodium Vivax Uncomplicated Treatment in Manokwari, West Papua | Biotech Hunter | Biotech Hunter